Moderna Inc (MRNA)

Current ratio

Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020 Dec 31, 2019 Sep 30, 2019 Jun 30, 2019 Mar 31, 2019
Total current assets US$ in thousands 10,325,000 10,799,000 10,599,000 12,122,000 13,431,000 14,297,000 13,563,000 16,350,000 16,071,000 13,425,000 10,969,000 11,703,000 6,298,000 3,577,210 2,796,740 1,249,940 1,128,800 1,094,470 1,097,420 1,140,830
Total current liabilities US$ in thousands 3,015,000 4,385,000 3,123,000 3,499,000 4,923,000 6,807,000 6,812,000 9,238,000 9,128,000 9,957,000 8,840,000 8,441,000 4,389,000 1,473,560 161,647 134,582 143,115 147,842 161,987 159,159
Current ratio 3.42 2.46 3.39 3.46 2.73 2.10 1.99 1.77 1.76 1.35 1.24 1.39 1.43 2.43 17.30 9.29 7.89 7.40 6.77 7.17

December 31, 2023 calculation

Current ratio = Total current assets ÷ Total current liabilities
= $10,325,000K ÷ $3,015,000K
= 3.42

The current ratio of Moderna Inc has exhibited fluctuations over the quarters analyzed. In Q4 2023, the current ratio stands at 3.42, indicating that the company has $3.42 in current assets for every $1 in current liabilities. This represents a strong liquidity position, suggesting that Moderna is well-equipped to cover its short-term obligations.

Comparing this with previous quarters, we observe a significant improvement from Q3 2023 (2.46) to Q4 2023, reflecting a better ability to meet short-term liabilities with current assets. Similarly, Q4 2023's current ratio is higher than in Q4 2022 (2.73), indicating enhanced liquidity management over the year.

The current trend suggests that Moderna has been efficiently managing its current assets and liabilities, resulting in improved liquidity ratios. Overall, the current ratio analysis indicates that Moderna Inc has strengthened its liquidity position, which is a positive signal for investors and stakeholders.


Peer comparison

Dec 31, 2023


See also:

Moderna Inc Current Ratio (Quarterly Data)